Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. (Q45767343)
Jump to navigation
Jump to search
scientific article published on 26 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. |
scientific article published on 26 July 2012 |
Statements
Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance (English)
Christopher J A Pugh
Christina Daousi
Andrew Irwin
Helen Jones
Valerie L Adams